Health Care Technology Impacts Younger Patient Satisfaction
Younger health care consumers are dissatisfied with technology capability of health care organizations
Most common medication error category was omitted medicine or ingredient
More female, black, and Hispanic matriculants seen after diversity accreditation standards implemented
The National Institutes of Health (NIH) announced Monday that it will soon embark on a major research effort to find scientific alternatives to human fetal tissue, a switch that may affect research ranging from basic science to drug trials. Human fetal tissue is commonly used by scientists to mimic human biology in order to understand normal development, study the effects of disease or test drugs. Its use in research is legal but fiercely opposed by some pro-life activists, given that it is procured after elective abortions. Over the next two years, the NIH will supply up to $20 million for research that seeks to “de...
Reasons for nondisclosure include not wanting to be judged or lectured, being embarrassed
Funding Opportunity RFA-AI-18-054 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote collaborative biomedical research between the United States and Brazil under the U.S.-Brazil Biomedical Collaborative Research Program. Research areas supported under this program include allergy, immunology, and infectious diseases, including HIV/AIDS and its co-morbidities; cancer; mother-to-child transmission of HIV and other congenital infections, early infant diagnosis and treatment; HIV/AIDS in relation to mental health; and neurological disorders and stroke.
Condition: HIV Infections Interventions: Drug: Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) Dispersible Tablets; Drug: Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC) Immediate Release Tablets (Immediate release) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); International Maternal Pediatric Adolescent AIDS Clinical Trials Network; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); ViiV Hea lthcare Ltd. Not yet recruiting
Coverage gains did not negatively impact employment levels, hours worked, earnings
An effective human immunodeficiency virus type 1 (HIV-1) vaccine has long been sought to contend with the Acquired Immunodeficiency Syndrome (AIDS) pandemic.One approach researchers have taken to elicit broadly neutralizing antibodies against HIV-1 is to stabilize the structurally flexible HIV-1 envelope (Env) trimer. Researchers stabilized the Env trimer in a conformation that displays predominantly broadly neutralizing epitopes and few non-neutralizing epitopes. Currently, BG505 DS-SOSIP is a leading vaccine candidate with the desired conformation and antigenicity.Ideally, to be useful as a vaccine, such a conformational...
More News: Allergy | Allergy & Immunology | Brain | Cancer & Oncology | Cardiology | Dermatology | Emergency Medicine | Endocrinology | Gastroenterology | Geriatrics | Health Management | Heart | HIV AIDS | Internal Medicine | Neurology | Nurses | Nursing | Opthalmology | Orthopaedics | Respiratory Medicine | Skin | Urology & Nephrology